Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 575-581

  Belanger, François ^a,b   Derouin, Francis ^a,b   Grangeot Keros, Liliane ^a,b   Meyer, Laurence ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY TITER; ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INFECTION SENSITIVITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; TOXOPLASMOSIS;

EID: 0033009662     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515147     Document Type: Article

References (28)

1. 1. USPHS/IDSA Prevention of Opportunistic Infections Working Group. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. Clin Infect Dis 1995; 21(suppl 1):S32-43.
2. 2. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15:211-22.
3. 3. Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA 1993; 269:76-7.
4. 4. Candolfi E, Partisani ML, De Mautort E, et al. Séroprévalence de la toxoplasmose chez 346 sujets infectés par le VIH dans l'Est de la France: suivi sérologique des sujets non contaminés par Toxoplasma gondii. Presse Med 1992; 21:394-5.
5. 5. Derouin F, Thulliez Ph, Garin YJF. Intérêt et limites de la sérologie de la toxoplasmose chez les sujet VIH+. Pathol Biol (Paris) 1991; 39:255-9.
6. 6. Richards FO, Kovacs JA, Luft BJ. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(suppl 1):S49-56.
7. 7. Derouin F, Leport C, Pueyo S, et al. Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. AIDS 1996; 10:1521-7.
8. 8. Hellerbrand C, Goebel FD, Disko R. High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996; 15:869-72.
9. 9. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990; 4:519-21.
10. 10. LaRocco A, Sanders JW, Myers JW. Central nervous system toxoplasmosis in AIDS. N Engl J Med 1993; 328:1353.
11. 11. Zufferey J, Sugar A, Rudaz P, Bille J, Glauser MP, Chave JP. Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1993; 12:591-5.
12. 12. Boufassa F, Carré N, Deveau C, et al. HEMOCO: a French prospective study on hemophiliacs infected by HIV-1. Hematol Cell Ther 1996; 38:193-8.
13. 13. Carré N, Deveau C, Belanger F, et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994; 8:797-802.
14. 14. Boufassa F, Bachmeyer C, Carré N, et al. Influence of neurologie manifestations of primary human immunodeficiency virus infection on disease progression. J Infect Dis 1995; 171:1190-5.
15. 15. Desmonts G, Couvreur J. Toxoplasmosis. In: Conn B, ed. Current diagnosis. Philadelphia: WB Saunders, 1985.
16. 16. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, 1995: 140-266.
17. 17. Diem K, Seldrup J. Geigy scientific tables. Vol. 2. Basel, Switzerland: Ciba-Geigy Ed, 1982.
18. 18. Cox DR. Regression models and life table. J R Stat Soc 1972; 34:187-220.
19. 19. Petithory JC, Ambroise-Thomas P, et al. Le sérodiagnostic de la toxoplasmose: étude comparative multicentrique d'une gamme d'étalon par les différents tests actuels et avec expression des résultats en unités internationales. Bull WHO 1996; 74:291-8.
20. 20. Ancelle T, Goulet V, Tirard-Fleury V, et al. La toxoplasmose chez la femme enceinte en France en 1995. Résultats d'une enquête nationale périnatale. Bulletin Epidémiologique Hebdomadaire 1996; 51:227-9.
21. 21. Israelski DM, Chmiel JS, Poggensee L, Phair JP, Remington JS. Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquir Immune Defic Syndr 1993; 6: 414-8.
22. 22. Gavinet MF, Robert F, Firtion G, et al. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol 1997; 35:1276-7.
23. 23. Hennequin C, Dureau P, N'Guyen L, Thulliez P, Cagelin B, Dufier JL. Congenital toxoplasmosis acquired from an immune woman. Pediatr Infect Dis J 1997; 16:75-7.
24. 24. Fortier B, Aissa E, Ajana F, et al. Spontaneous abortion and reinfection by Toxoplasma gondii. Lancet 1991; 338:444.
25. 25. Araujo F, Slifer T, Kim S. Chronic infection with Toxoplasma gondii does not prevent acute disease or colonization of the brain with tissue cysts following reinfection with different strains of the parasite. J Parasitol 1997; 83:521-2.
26. 26. Hunter CA, Remington JS. Immunopathogenesis of toxoplasmic encephalitis. J Infect Dis 1994; 170:1057-67.
27. 27. Carrega G, Canessa A, Argenta P, Cruciani M, Bassetti D. T-cell blastogenic responses to Toxoplasma gondii trophozoites among HIV-infected patients. AIDS Res Hum Retroviruses 1995; 11:741-6.
28. 28. Derouin F, Rabian-Herzog C, Ballet JJ. Impaired in vitro lymphocyte response to Toxoplasma antigen in HIV-1-infected patients. J Clin Lab Immunol 1989; 28:179-82.